Quadrupole Time-of-Flight LC-MS
四极杆飞行时间 LC-MS
基本信息
- 批准号:10176802
- 负责人:
- 金额:$ 53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-15 至 2022-04-14
- 项目状态:已结题
- 来源:
- 关键词:3 year old8 year oldAcuteAgingAlcoholsAortic AneurysmAsthmaBiological MarkersCardiovascular systemCell MobilityCellsClinicDataDegenerative polyarthritisDimensionsEventExtracellular MatrixFatty LiverGlioblastomaGoalsLaboratoriesLiver diseasesPlasmaProteinsProteomeProteomicsResearch InstituteResourcesRisk FactorsRunningSamplingScanningSystemTimeWait TimeWorkloadbaseexperimental studygut microbesinstrumention mobilitymouse modelnon-alcoholictrimethyloxamine
项目摘要
Abstract
This proposal is for the acquisition of a Bruker timsTOF Pro instrument to be placed in the Proteomics
Shared laboratory Resource (SLR) at the Lerner Research Institute at the Cleveland Clinic. The
Proteomics SLR is equipped with two LC-MS/MS systems including an eight year old ThermoScientific
Orbitrap Elite and a three year old ThermoScientific Fusion Lumos system. The Proteomics SLR is
currently running at capacity, with over 45% of the current experiments involving quantitative proteomic
projects. The current workload of the Proteomics SLR has resulted in long wait times for proteomic
experiments that involve the analysis of more than 20 samples. The large workload and subsequent
wait times are exasperated by the low throughput workflow of the Elite and Lumos instruments, each
instrument analyzing approximately 8 samples per day. The goal of this proposal is twofold and
includes increasing the capacity of the Proteomics SLR and, more importantly, to expand the
capabilities of the SLR to include high throughput proteomic experiments. The timsTOF Pro instrument
is a fast scanning quadrupole time of flight instrument and was selected for this proposal based on
data that indicates that this instrument can analyze between 40-100 samples per day without sacrificing
proteome depth, sensitivity, accuracy and robustness. A comparison of a DIA based proteomic
analysis of a tryptic digest generated from a cell lysate on the Lumos housed in the Proteomics SLR
and the timsTOF Pro instrument showed that the timsTOF Pro quantified more proteins in a 30 minute
gradient (over 4800) compared to a 90 minute gradient on the Lumos instrument (3000). This
increased proteome depth is due to the higher scan rates, 100 Hz, of the timsTOF Pro, along with an
additional dimension of separation (ion mobility), and the capability of this instrument to perform Parallel
Accumulation Serial Fragmentation (PASEF) which allows synchronization of the quadrupole mass filter
with the tims ion mobility cell. There are several studies that would benefit from access to the timsTOF
Pro. These include studies of mouse models of alcohol-associated liver disease and non-alcoholic
associated fatty liver disease (Nagy), the analysis of alterations to the sulhydrome that occur in ageing
(Hine), a study of the signatures that are acutely altered by the gut microbe-derived metabolites TMA and
TMAO (Brown), studies to better understand the mechanisms of glioblastoma (Lathia), identification of
risk factors for major cardiovascular events (Hazen), identification of plasma biomarkers of severe
asthma (Li), and the study of ECM remodeling that occurs in aortic aneurysms (AAA) and osteoarthritis
(Apte).
摘要
该提案旨在收购一台布鲁克timsTOF Pro仪器,用于蛋白质组学研究。
克利夫兰诊所勒纳研究所的共享实验室资源(SLR)。的
Proteomics SLR配备了两个LC-MS/MS系统,包括一个已有八年历史的ThermoScientific
Orbitrap Elite和三年前的ThermoScientific Fusion Lumos系统。Proteomics SLR
目前正在满负荷运行,目前超过45%的实验涉及定量蛋白质组学
项目蛋白质组学SLR目前的工作量导致蛋白质组学的等待时间很长,
实验涉及20多个样品的分析。巨大的工作量和随后的
Elite和Lumos仪器的低通量工作流程增加了等待时间,
仪器每天分析大约8个样品。这项建议的目的有两个,
包括增加蛋白质组学SLR的容量,更重要的是,
SLR的能力包括高通量蛋白质组学实验。timsTOF Pro仪器
是一种快速扫描四极杆飞行时间仪器,
数据表明,该仪器每天可以分析40-100个样品,
蛋白质组深度、灵敏度、准确度和鲁棒性。基于DIA的蛋白质组学方法的比较
分析Proteomics SLR中Lumos上细胞裂解物产生的胰蛋白酶消化物
timsTOF Pro仪器显示,在30分钟内,
梯度(超过4800)与Lumos仪器(3000)上的90分钟梯度相比。这
增加的蛋白质组深度是由于更高的扫描速率,100 Hz,timsTOF Pro,沿着
分离的额外维度(离子迁移率),以及该仪器执行平行
累积串联裂解(PASEF),允许四极质量过滤器同步
离子迁移率电池。有几项研究将受益于timsTOF的访问
Pro.这些研究包括酒精相关性肝病和非酒精性肝病的小鼠模型的研究。
相关脂肪肝(Nagy),分析衰老过程中发生的巯基变化
(Hine),一项关于肠道微生物衍生代谢物TMA和
TMAO(布朗),研究,以更好地了解胶质母细胞瘤(Lathia)的机制,识别
主要心血管事件的风险因素(哈岑),严重心血管事件的血浆生物标志物的鉴定
哮喘(Li),以及发生在主动脉瘤(AAA)和骨关节炎中的ECM重塑的研究
(Apte).
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A novel strategy to characterize the pattern of β-lactam antibiotic-induced drug resistance in Acinetobacter baumannii.
一种表征鲍曼不动杆菌β-内酰胺抗生素诱导耐药性模式的新策略。
- DOI:10.21203/rs.3.rs-2359505/v1
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Hillyer,Trae;Benin,BogdanM;Sun,Chuanqi;Aguirre,Noah;Willard,Belinda;Sham,YukYin;Shin,WooShik
- 通讯作者:Shin,WooShik
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Belinda Belle Willard其他文献
Belinda Belle Willard的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Belinda Belle Willard', 18)}}的其他基金
相似海外基金
Neurolinguistic development in 4 to 8 year-old late talkers with language delay
语言迟缓的 4 至 8 岁说话晚者的神经语言发育
- 批准号:
10539603 - 财政年份:2023
- 资助金额:
$ 53万 - 项目类别:
The effect of in-utero exposure to metformin in 5-8 year old offspring of mothers in the MiTy Trial (MiTy Tykes)
MiTy 试验 (MiTy Tykes) 中子宫内暴露于二甲双胍对母亲 5-8 岁后代的影响
- 批准号:
432867 - 财政年份:2020
- 资助金额:
$ 53万 - 项目类别:
Operating Grants
Bone strength in 8 year old children: influence of preg nancy, early childhood and current lifestyle factor
8 岁儿童的骨强度:怀孕、幼儿期和当前生活方式因素的影响
- 批准号:
nhmrc : 961030 - 财政年份:1996
- 资助金额:
$ 53万 - 项目类别:
NHMRC Project Grants














{{item.name}}会员




